Global Impact launches new $5 million research fund

Alexandria, Virginia, Aug. 05, 2022 (GLOBE NEWSWIRE) — Global Impact, on behalf of the Alliance for Advancing Health Online (AAHO), is pleased to announce the launch of a new round of Requests for Proposals (RFPs) for the Vaccine Trust Fund (VCF). The VCF is a program of AAHO and is financially supported by Meta and Merck & Co., Inc., Rahway, NJ USA (known as MSD outside the United States and Canada). This round of global research funding will focus on harnessing the power of social media to increase trust and uptake of immunization, with a focus on improving routine immunization and educating health workers on addressing vaccine hesitancy. Global Impact releases the Full Insights report on the first Vaccine Confidence Fund, which features grantee research findings and insights into potential ways to build confidence and uptake of vaccination.

Following the success of last year’s open call, managed by Global Impact, where the Fund solicited proposals that address how best to use social media to better understand vaccine hesitancy and increase confidence and uptake of vaccination, this additional round will build on the insights of the 33 alumni around the world will continue to pursue new and transformative approaches using social media and behavioral science to bring new information on COVID-19 and routine vaccination in communities.

“We were thrilled to see the results of the first Vaccine Confidence Fund and to learn how organizations around the world are using social media to achieve positive health outcomes,” said Lu’chen Foster, Head of Healthcare Partnerships at Meta. “We look forward to seeing more innovative projects with the next round of research.”

Grantees will be selected through a competitive and open process managed by Global Impact, the fiscal sponsor and fund manager, with the support of the VCF Advisory Council, a small interdisciplinary group of experts in the field of trust in the immunization, public health, social media, and behavioral and data science fields. Selected projects will use a variety of innovative research approaches and explore how behavioral nudges, natural language processing, use of chatbots, and targeted influencers impact vaccination trust and uptake. vaccine.

“We are honored to be a founding member of the Alliance for Advancing Health e-Health (AAHO) and are excited about the early insights from the Vaccine Confidence Fund’s research and how they are helping to fill lack of research and knowledge on how to reach hesitant populations. through social media » said Michael D. Fornwall, Associate Vice President, Vaccination Confidence, Merck & Co., Inc., Rahway, NJ USA (known as MSD outside the United States and Canada). “We are proud to financially support this next round of research to continue advancing knowledge to improve the health and resilience of communities around the world. »

The report and open tender were announced ahead of the Insights Dialogue event, “Using Social Media to Increase Trust in Vaccines”, on Tuesday August 9 at 13:00 GMT, where speakers will discuss key vaccine study findings. Confidence Fund and share best practices from projects implemented in Guatemala, Algeria, Kenya, USA and UK. Participants are invited to discover how grantees have effectively harnessed the capabilities of social media platforms and designed effective engagement activities and personalized, targeted messages to increase immunization confidence in marginalized and underserved communities.

For more information, please visit vaccineconfidencefund.org.

About the AAHO
The Alliance for Advancing Health Online (AAHO) is a newly formed and evolving coalition of stakeholders from technology, health, global development and academia who are united to explore how social media and online engagement can improve the health and resilience of communities around the world. Currently, stakeholders involved in AAHO include the Bay Area Global Health Alliance, CDC Foundation, MIT Digital Economy Initiative, Sabin Vaccine Institute, Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, the World Bank, and the World Health Organization. The multi-year, $40 million initiative, funded by Meta and Merck & Co., Inc., Rahway, NJ USA (known as MSD outside the United States and Canada), will initially focus on reluctance immunization and vaccine equity with a strong focus on historically excluded or marginalized communities.

About Global Impact
Global Impact works on charitable ventures to inspire more giving and serves as a trusted advisor, broker, and implementation partner in the private, nonprofit, and public sectors. Through these partnerships, Global Impact has raised nearly $2 billion for causes including disaster relief and global development. Global Impact’s reach and services are complemented by the work of its subsidiary, Geneva Global.


Comments are closed.